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Shivanthi Balalla,1,* Chris Krägeloh,1 Oleg Medvedev,2 and Richard Siegert1
Abstract
Persistent post-concussion syndrome (PCS) symptoms are known to last years after traumatic brain injury (TBI),
and similar symptoms are increasingly being documented among those who have not experienced a TBI. There
remains however, a dearth of empirical evidence on the structural composition of symptoms beyond the post-
acute symptom phase after TBI, and little is known about the potential use of PCS symptom scales to measure
PCS-like symptoms in non-TBI individuals. Our objective was therefore to examine the psychometric perfor-
mance and dimensionality of the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) as a measure of
long-term PCS symptoms among a TBI and non-TBI sample. A case-control sample of 223 patients with injury,
consisting of age- and sex-matched TBI participants (n = 109) and orthopedic participants (n = 114) were
recruited from a regional trauma registry in New Zealand (NZ), and assessed at mean 2.5 years post-injury. Results
from the Rasch analysis showed that the RPQ achieved fit to the Rasch model, demonstrating very good reliabil-
ity (Person Separation Index [PSI] = 0.87), thereby indicating that the measure can be used reliably for individual
and group assessment of symptoms among both TBI and orthopedic patients. In this study we demonstrated
evidence of a unidimensional construct of PCS symptoms in both groups, which helps alleviate previous uncer-
tainty about factor structure, and permits the calculation of a total RPQ score. Conversion of ordinal to interval
total scores presented within are recommended for clinicians and researchers, to improve instrument precision,
and to facilitate the interpretation of change scores and use of parametric methods in data analysis.
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Introduction
Traumatic brain injury (TBI) has myriad consequences
that can have lasting effects on cognition, physical and
psychological functioning, return to employment, so-
cial reintegration, and quality of life.1–3 Among the
most commonly persisting difficulties associated with
TBI is the onset of post-concussion syndrome (PCS)
symptoms, which are a constellation of neurological
and neuropsychological symptoms including headache,
dizziness, irritability, anxiety, depression, fatigue, and
difficulties with memory and concentration.4 Symp-
toms of PCS are particularly prevalent among those
who have experienced mild TBI,5 and are known to
last from hours after trauma up to 10 years after injury.6,7
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Factors such as cognitive and somatic symptoms im-
mediately after injury, pre-existing depression, past his-
tory of TBI, and sleep quality have been found to
increase the chronicity of symptoms.8
The Rivermead Post-Concussion Symptoms Ques-
tionnaire (RPQ)9 is one of the most widely used scales
to assess PCS symptoms following TBI, and has dem-
onstrated good internal consistency, test-retest, and
inter-rater reliability.9–11 Previous research utilizing
both classical approaches of factor analysis and more
modern psychometric techniques such as Rasch analy-
sis has consistently pointed to multi-dimensionality
existing within the scale, especially when used with pa-
tients in the early recovery period.11–13 Variable factor
structures have been proposed comprising two, three,
or four dimensions underpinning PCS symptoms;
however, there is a lack of consensus as to the most
consistent structure.14 Further fueling the ongoing de-
bate is the non-specificity of PCS symptoms as a phe-
nomenon solely attributable to the experience of a
TBI, given that symptoms arise in various groups in-
cluding those with chronic pain,15 psychological disor-
ders,16 orthopedic injuries,17 and even within the
healthy population.8 Despite the burgeoning evidence
across such diverse samples, the psychometric utility
of these PCS symptom scales has not yet been exam-
ined in non-TBI populations.
The application of modern psychometric approaches
such as Rasch analysis for scale validation offers several
advantages over factor analysis. The Rasch measure-
ment model accounts for the probability of a person
endorsing a Likert-scale item at a particular value as
a function of two important parameters—the difficulty
of an item and the amount of a trait held by a person,
or the so-called person ability.18 These two parame-
ters are represented on the same logarithmic interval
scale, which is a central tenet of the Rasch model. An
added advantage of Rasch analysis is that it offers de-
tailed information about the performance of individ-
ual items, including to what extent an item functions
consistently by a demographic feature such as by age
group, sex, or injury type. An important feature of
Rasch analysis is that once a measure has been
shown to meet the requirements of the Rasch model,
ordinal scales can be transformed to an interval-level
scale that not only ensures measurements are more
precise, but also permits the use of more robust para-
metric data analyses without violating fundamental
assumptions. As this transformation adjusts for differ-
ences in item difficulty, scores on the Rasch model
interval scale therefore represent a more accurate
reflection of a person’s trait level.
Rasch analysis can present novel ways to resolve cur-
rent ambiguities around dimensionality of the RPQ in
the TBI population, which may be underpinned by is-
sues such as local response dependency or local trait
dependency. Past attempts to resolve discrepancies
around factor structure have been conducted with the
application of Rasch methods, but as of yet they have
not resulted in a consistent solution.11,12 Previous ex-
aminations of the RPQ have also not extended beyond
the first year after TBI, with many focussing only on
the acute symptom phase, namely 3–6 months post-
TBI. Symptoms are known to persist many years
after injury,6,7,13 and currently there remains a dearth
of evidence regarding the structural composition of
symptoms in the mid-to-late recovery period after TBI.
The present Rasch investigation aimed to elucidate
on the obscurities regarding the dimensionality of the
RPQ by utilizing a subtest approach to control for
method effects, to evaluate long-term post-concussion
symptoms that are present at approximately 2.5 years
after TBI. As validation of PCS symptom scales in
non-TBI populations does not currently exist, this
study also aimed to examine whether the RPQ can be
reliably administered as a measure of PCS-like symp-
toms, in a control injury sample consisting of par-
ticipants with orthopedic injuries. In line with best
practice guidelines for Rasch analyses19 we have pre-
sented conversion tables for raw total-ordinal to total-
interval scores to increase instrument precision. These
transformations enable clinicians and researchers to




Patients diagnosed with a TBI or an orthopedic injury
and discharged alive between 2012 and 2016 (n = 1090),
were recruited for initial contact from a regional hospi-
tal registry in the Waikato region of New Zealand (NZ).
Injuries were defined by relevant Abbreviated Injury
Scale 2005–08 codes.20 As per World Health Organiza-
tion guidelines21 a TBI diagnosis was recorded in the
registry where there was evidence of a cerebellum
injury, hematoma, contusion, diffuse axonal injury,
brain swelling, loss of consciousness, alteration of
mental state, or presence of post-traumatic amnesia.
The TBI group consisted of both isolated TBI and
multiple-injury TBI cases (TBI and extracranial injuries).
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Orthopedic injuries included joint injuries relating to
fractures, dislocations, or sprains to the pelvic region,
and upper and lower extremities. Orthopedic injuries
resulting from ‘‘insufficiency’’ or stress fractures, pre-
existing medical conditions (e.g., epilepsy, Parkinson’s
disease), or without evidence of external force were ex-
cluded. Participants who were unable to give consent
due to language barriers (i.e., non-English speaking)
or who had cognitive or hearing impairments were ex-
cluded, as well as those who had likely experienced sig-
nificant psychological trauma due to the nature of their
injuries (e.g., crushes and amputations).
Clinical injury details including Glasgow Coma Scale
(GCS) score and Injury Severity Score (ISS) were
obtained from registry data. Follow-up interviews
were conducted between 6 months and 6 years post-
injury and administered via telephone interview by the
primary investigator. Informed consent was obtained
through audio-tape recording. Final response rates of
38% and 39%, yielded a total of 109 TBI and 114 or-
thopedic cases, respectively, with participants being
matched by age (5-year bands) and sex. There were
no significant differences between respondents and
non-respondents except for ethnic group and discharge
destination. Ethical approval was granted by the insti-
tutional, hospital, and national ethics committees.
Outcome measures
The RPQ is a 16-item self-report questionnaire that
assesses the severity of 16 different PCS symptoms
that typically follow TBI. Participants were asked to
rate their symptoms before and after their injury and
also to rate the severity of their symptoms in the last
24 h. Items follow a 5-point ordinal rating system
where 0 = never experienced at all, 1 = no more of a
problem, 2 = a mild problem, 3 = a moderate problem,
and 4 = a severe problem. Thus total scores using the
sum of all items can theoretically range from 0 to
64,12 although due to reported differences in dimen-
sionality there is no gold standard on the scale’s scor-
ing structure.22 The Cumulative Illness Rating Scale
(CIRS)23 to assess comorbidity, and the World Health
Organization Quality of Life Brief Version (WHOQoL-
BREF) tool to assess health-related quality of life2 were
also administered at the time of interview.
Sample descriptives and data analysis
Descriptive statistics were calculated using IBM SPSS
software version 25. Except for GCS scores, missing
data were less than 1% and at random order. The sam-
ple size met the requirements to estimate person mea-
sures to –0.5 logits within 99% confidence intervals for
Rasch analyses,24 and was powered at 0.80 beta to de-
tect moderate effect sizes between d = 0.30–0.40, at
0.05 alpha. Table 1 presents the sample demographics
and clinical characteristics. Mean injury time between
TBI and orthopedic groups was 2.5 and 2.7 years respec-
tively ( p = 0.289). Both injury groups were classified as
minor trauma (ISS <16) but participants with TBI had
marginally higher injury severity than orthopedic patients,
ISS 11.0 and 4.0, respectively ( p < 0.001), as well as lon-
ger hospital stays ( p < 0.05). For the TBI sample, median
GCS of 14.0 (of the 66% of GCS scores that were avail-
able) indicated a predominance of mild TBI.
For Rasch analyses, similar procedures employed
by other Rasch studies2,25 were followed using the
Rasch Unidimensional Measurement Model (RUMM)
2030 software,26 including the assessment of item-
level and overall fit to the Rasch model, scale reliability,
unidimensionality, scale targeting, threshold ordering,
response dependency, and differential item functioning
(DIF). A likelihood ratio test indicated the appropriate
use of the polytomous Partial Credit Model27 over the
Rasch Rating Scale Model28 (v2[44] = 150.60, p < 0.001).
Super-items or subtests were also created by merging
related items to correct for method effects and to ad-
dress deviations of the Rasch model. Further details
of each procedure are presented in Table 2.





(n = 114) P-value
Mean age,
years (SD)
48.8 (19.7) 48.0 (19.7) 0.905a
Median ISS 11.0 4.0 0.000*,b




2.5 (0.13) 2.7 (0.04) 0.289a
Sex Male 63.3 64.9 0.802c








Marital status % Single 46.3 40.7 0.402c
Living as married 53.7 59.3
*Significant at p < 0.05.
at test; bMann-Whitney U; cv2 test.
‘‘Other’’ ethnic group consists of Maori, Pacific, Asian, and other ethnic
minority groups; ‘‘Single’’ status refers to divorced, separated, widowed,
and never married; ‘‘Living as married’’ refers to de facto and married.
ISS, Injury Severity Score; LOS, length of hospital stay in days; NZ, New
Zealand; SD, standard deviation; TBI, traumatic brain injury.
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Where unidimensionality was met, a total score was
derived using the sum of all 16 items.12 In line with
guidelines for Rasch studies,19 presented in Supple-
mentary Table S1 are conversions of raw ordinal to in-
terval total scores (adjusted for both person ability/trait
level and item difficulty), to improve accuracy where
total scores are used.
Results
Item-level fit statistics are presented in Table 3 along-
side percentage of symptom endorsement by injury
group. Distribution patterns of symptom endorsement
were similar in both groups, with most participants
reporting that each symptom was either not experi-
enced post-injury or was not a current problem. In
the total sample, only 1.8% of participants with TBI
and 14.5% of orthopedic participants had not experi-
enced any symptoms after injuries (v2Yates[1] = 9.59,
p = 0.002). In comparison, 67.9% TBI and 37.7% ortho-
pedic participants endorsed experiencing at least one
current PCS symptom (v2Yates[1] = 20.34, p < 0.001),
out of which the majority (approximately 85%) in
both injury groups reported mild symptoms only
(v2Yates[1] = 0.04, p = 0.840). Participants with TBI
scored higher than the orthopedic group on most
items ( p < 0.05), except on symptoms of ‘‘sleep distur-
bance’’ (item 5) and ‘‘restlessness’’ (item 16).
Summary statistics for the overall Rasch model fit
are presented in Table 4. Preliminary Rasch analyses
of the 16-item scale demonstrated good reliability (Per-
son Separation Index [PSI] = 0.84) and unidimension-
ality; however, the data did not meet the expectations
of the Rasch model due to significant interaction be-
tween items and the overall symptoms. Closer exami-
nation of the individual items presented in Table 3
showed that items ‘‘sleep disturbance,’’ ‘‘poor concen-
tration,’’ and ‘‘longer to think’’ had significant misfit
to the Rasch model exceeding the –2.50 acceptable
threshold. In general, items on physical symptoms
such as dizziness, nausea, and vision had the highest
item locations indicating that participants were less
likely to endorse these symptoms than others. Affective
or cognitive symptoms (e.g., sleep, fatigue frustration,
and memory problems) in comparison, were more
readily endorsed by participants.
Table 2. Description of Procedures Undertaken for Rasch Analysis
Concept examined Description of procedure
Overall Rasch
model fit
Where data fit the Rasch model, chi-square (v2) estimate should indicate that item-trait interaction is not significant
(Bonferroni adjusted p > 0.05), and means and standard deviations for overall item and person fit residuals are close to
1.00 and 0.00, respectively. A significant v2 reflects the presence of local trait dependency, indicating that the hierarchical
ordering of items (item difficulty) varies across the trait or construct.17
Fit residuals for individual items should also fall in the range of -2.50 to +2.50 to demonstrate fit to the Rasch model.40
Unidimensionality Presence of unidimensionality is assessed by a principal component analysis of residuals where no further remaining
associations among residuals are detected once the latent trait or Rasch component has been extracted. This is
indicated by an independent t test where the percentage of significant t tests beyond +1.96 confidence intervals is <5%,
and/or the lower bound confidence interval of significant tests overlaps the 5% mark.41
Reliability Scale reliability is denoted by the Person Separation Index (PSI), which is equivalent to Cronbach’s alpha. Values >0.70
permit group comparisons, and values >0.85 allow for individual assessment.42
Targeting of persons
and items
For ideal targeting of a measure to person ability, the mean location should be centred around 0.00. Positive values
indicate that the sample is located at a higher level of the construct, compared with the average of the scale, and the
converse would be true for negative values.
Differential item
functioning
Differential item functioning (DIF) refers to the effect that a particular item does not perform consistently across
demographic features. In this study, DIF was assessed by age, sex, marital status (single/living as married), ethnic group
(NZ European vs. Other), education (Primary/High school vs. Polytechnic/University), injury group (TBI vs. orthopedic),
and time since injury (0-2.5 years vs. 2.5-6 years). Further, using a post hoc sign test of significance, the distinction was
made between real DIF (or significant DIF) and artificial DIF, where the latter is said to occur spuriously as an artifact of
the method for detecting DIF.43
Ordering of response
thresholds
Response thresholds were examined visually using category probability curves. The presence of significantly disordered
response thresholds would indicate that item response categories are problematic and do not work as expected.
Local response
dependency
Presence of local response dependency (indicating item responses influencing one another) can be examined by looking




Violations of Rasch model assumptions including the presence of DIF, local dependency, and threshold disordering were
addressed with the pairing of related items (based on their residual correlations) to create subtests or ‘‘super-items.’’
Super-items attenuate measurement error that exists within individual items.45
NZ, New Zealand; TBI, traumatic brain injury.
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There were indications of DIF by injury group for
items ‘‘sleep disturbance’’ and ‘‘forgetfulness,’’ which
were confirmed to be artificial. DIF by age, sex, ethnic
group, education level, marital status, or time since in-
jury was not evident. Examination of the residual cor-
relations also indicated the presence of local response
dependency among several items, suggesting that re-
sponses to items may be influenced by one another
due to potential method effects. To reduce measure-
ment error affecting fit to the Rasch model and to cor-
rect for local response dependency, related items were
subsequently paired based on residual correlations to
create eight super-items: 1 + 9, 2 + 7, 3 + 12, 4 + 16,
5 + 10, 6 + 11, 8 + 13, 14 + 15. Analysis of the eight
super-items showed a considerable improvement and
yielded strong fit to the Rasch model (v2[72] =
63.77, p = 0.74), with evidence of unidimensionality
and improved reliability (PSI = 0.87).
As shown in Figure 1, the targeting of items to per-
sons was suboptimal. For participants with TBI, the
person mean was 1.43 (standard deviation [SD] =
1.56), deviating from the ideal value of 0.00. However,
only a relatively minor floor effect was detected, with
around 12% of participants with TBI not covered by
the scale. In comparison, item-person targeting was
poor for participants in the orthopedic sample (2.94,
SD = 1.59), who presented with no or very minor symp-
toms, and a thus considerable degree of floor effect
(about 50%) was noticeable for this group.
Altering of scale parameters by virtue of Rasch trans-
formation from ordinal-to-interval-level scores dem-
onstrated a significant within-participant difference
between scores (t[222] =33.13, p < 0.001), as shown
in Table 5. This means that, as per our conversions
in Supplementary Table S1, a raw total score of 2
means an individual’s total score is 10.40 at the interval
Table 3. Item-level Rasch Model Fit Statistics for the Initial Analysis of the 16-item RPQ with Item Locations, Fit Residuals,
Chi-Square Statistics, and % of Participants Endorsing Symptoms by Response Category and Injury Group
% Endorsing symptom category
Location SE Fit Resid w2 Prob
TBI Orthopedic
SigaRPQ item 0 1 2 3 4 0 1 2 3 4
1 Headaches -0.17 0.10 0.08 7.54 0.581 37 47 9 4 4 72 20 4 4 0 0.000*
2 Feelings of dizziness 0.65 0.12 -0.31 5.86 0.754 36 50 11 3 0 76 21 1 2 0 0.000*
3 Nausea and/or vomiting 1.54 0.15 1.03 5.49 0.790 56 42 2 0 0 76 23 1 0 0 0.009*
4 Noise sensitivity, easily upset by loud noise 0.16 0.10 -1.68 8.54 0.480 48 34 10 6 2 86 10 3 2 0 0.000*
5 Sleep disturbance -0.44 0.08 2.86 27.43 0.001 50 24 6 16 5 46 40 5 8 0 0.571
6 Fatigue, tiring more easily -0.87 0.09 -0.26 15.23 0.085 21 40 14 22 3 40 38 11 8 3 0.024*
7 Being irritable, easily angered -0.52 0.09 -0.80 3.28 0.952 37 36 8 14 6 59 28 9 3 2 0.003*
8 Feeling depressed or tearful -0.13 0.09 -0.40 5.24 0.813 45 32 12 9 2 64 27 4 4 1 0.006*
9 Feeling frustrated or impatient -0.80 0.09 -1.33 8.72 0.464 22 42 16 14 6 40 46 8 4 1 0.001*
10 Forgetfulness, poor memory -0.53 0.09 -0.77 7.33 0.602 19 36 21 18 6 76 12 6 5 0 0.000*
11 Poor concentration -0.30 0.09 -2.88 14.85 0.095 38 32 12 13 6 75 17 4 4 0 0.000*
12 Taking longer to think -0.52 0.08 -2.80 11.34 0.253 28 31 18 16 6 72 19 4 4 1 0.000*
13 Blurred vision 0.56 0.11 0.41 13.43 0.144 71 19 5 5 1 85 11 3 1 0 0.032*
14 Light sensitivity, easily upset by bright light 0.79 0.11 -0.32 8.15 0.519 61 29 6 5 0 84 10 3 4 0 0.001*
15 Double vision 0.91 0.18 -0.86 5.08 0.828 81 17 0 1 1 96 4 0 0 0 0.002*
16 Restlessness -0.32 0.09 0.50 21.49 0.011 48 30 12 6 5 60 32 6 2 1 0.091
0 = not experienced at all; 1 = no more of a problem; 2 = mild problem; 3 = moderate problem; 4 = severe problem.
*Denotes statistical significance at p < 0.05.
aMann-Whitney U test for comparing mean rank ordinal scores for TBI and orthopedic groups at individual item-level.
Bold indicates significant misfit to the Rasch model.
RPQ, Rivermead Post-Concussion Symptoms Questionnaire; SE, standard error; TBI, traumatic brain injury.
Table 4. Summary of Fit Statistics for Initial and Final Rasch Analyses of the 16-Item RPQ
RPQ analyses
Item fit residual Person fit residual Goodness of fit
PSI
Significant t tests
Value / SD Value / SD w2 (df) P % % Lower bound (unidimensionality)
Initial (16) -0.47 1.40 -0.30 0.95 111.37 (80) 0.01 0.84 9.87 0.48 (NO)
Super-items (8)a -0.49 0.67 -0.37 1.02 63.77 (72) 0.74 0.87 3.59 0.73 (YES)
aSuper-items were created based on residual correlations: ‘‘headaches-frustrated,’’ ‘‘dizziness-irritability,’’ ‘‘nausea-longer to think,’’ ‘‘noise sensitivity-
restlessness,’’ ‘‘sleep disturbance-forgetfulness,’’ ‘‘fatigue-poor concentration,’’ ‘‘depressed-blurred vision,’’ and ‘‘light sensitivity-double vision.’’
df, degrees of freedom; PSI, Person Separation Index; RPQ, Rivermead Post-Concussion Symptoms Questionnaire; SD, standard deviation.
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level, having adjusted for item difficulty and person
ability. As expected, participants with TBI showed
higher total RPQ scores for both ordinal and Rasch-
converted interval measures. Among demographic var-
iables, younger participants appeared to report higher
levels of symptoms in both TBI and orthopedic groups
(Table 6). Interestingly, longer hospitalization (rs = 0.40)
and increased ISS (rs = 0.39) correlated significantly
with higher RPQ interval scores, but only among or-
thopedic participants ( p < 0.001). GCS scores were
not correlated with RPQ scores ( p > 0.05) for partici-
pants with TBI.
FIG. 1. Person-item threshold distribution for the 16-item RPQ. The blue bars indicate the TBI subsample
(n = 109) and the red bars the orthopedic subsample (n = 114). In the top half, negative values (locations)
represent individuals on the lower end of the PCS symptoms spectrum, whereas in the bottom half, negative
locations indicate items that were most frequently endorsed by the sample. Conversely, positive locations indicate
those with higher levels of PCS symptoms, or items that were least readily endorsed by respondents. PCS, post-
concussion syndrome; RPQ, Rivermead Post-Concussion Symptoms Questionnaire; TBI, traumatic brain injury.
Table 5. Comparisons of RPQ Rasch-Transformed-Interval
and Ordinal-Level Total Scores
RPQ Injury group Mean SD Sig.
Interval scores TBI 26.45 10.77 0.000*,a
Orthopedic 16.71 11.02
Ordinal scores TBI 15.16 10.58 0.000*,b
Orthopedic 6.94 7.36
*Significant at p < 0.05.
at test; bMann-Whitney U test.
Ordinal total scores were only calculated for the purposes of demon-
strating differences with interval scores
RPQ, Rivermead Post-Concussion Symptoms Questionnaire; SD, stan-
dard deviation; TBI, traumatic brain injury.
Table 6. Spearman Correlations between RPQ Interval
Scores, Injury Factors, Comorbidity and Quality of Life





Time since injury (years) 0.06 -0.13
Length of hospital stay 0.15 0.40**
ISS -0.07 0.39**
GCSa -0.17 -0.30
Pre-injury total comorbidityb 0.06 0.06
Prior musculoskeletalb 0.05 0.17
Prior neurologicalb 0.20* 0.15
Prior psychologicalb 0.25* 0.18*
Post-injury total comorbidityb 0.27** 0.28**
Post-injury musculoskeletalb 0.29** 0.24**
Post-injury neurologicalb 0.33** 0.34**
Post-injury psychologicalb 0.40** 0.39**
WHOQoL-BREF total interval scorec -0.68** -0.47**
Physical domainc -0.58** -0.47**
Psychological domainc -0.67** -0.39**
Social domainc -0.32** -0.29**
Environmental domainc -0.65** -0.40**
*Significance at p < 0.05; **significance at p < 0.001.
aGCS scores, which were only available for 69% of TBI and 17% of
orthopedic participants; bordinal-level comorbidity scores on the Cumu-
lative Illness Rating Scale; ctotal interval and domain-level scores for the
24-item WHOQoL-BREF excluding global items 1 and 2.
GCS, Glasgow Coma Scale; ISS, Injury Severity Score; RPQ, Rivermead
Post-Concussion Symptoms Questionnaire; WHOQoL-BREF, World Health
Organization Quality of Life Brief Version.
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Although pre-injury total comorbid illness as mea-
sured by the CIRS did not have an association with
total RPQ scores, prior neurological and psychological
problems did show a weak association with PCS symp-
toms (rs = 0.20 0.25), especially for those with TBI.
Post-injury comorbidity in comparison, demonstrated
stronger associations with RPQ scores in both groups
(rs = 0.27 0.28), particularly for post-injury neurolog-
ical (rs = 0.33 0.34) and psychological disturbances
(rs = 0.39 0.40). RPQ interval scores demonstrated
good concurrent validity with WHOQOL scores in
both samples (rs =0.47 to0.68), notably for the phys-
ical (rs =0.47 to 0.58), psychological (rs =0.39
to 0.67), and environmental domains (rs =0.40 to
0.65).
Discussion
The aim of this Rasch examination of the RPQ was to
explore the dimensionality of persistent PCS symptoms
occurring at 2.5 years after TBI, and to clarify previous
inconsistencies on factor structure. Further, the study
aimed to validate the RPQ for use with non-TBI sam-
ples, which has not been done previously. Our findings
indicate that the RPQ achieves good fit to the Rasch
model, demonstrating strong reliability in both TBI
and orthopedic groups. A reliability coefficient of
0.87 is congruent with values reported by other Rasch
studies,11,12 and indicates the measure’s usefulness
across group comparisons, as well as for individual as-
sessment of symptoms. Further examination indicates
that the scale covers close to 90% of the TBI sample,
and items function invariantly by age, sex, marital sta-
tus, ethnicity, time since injury, and injury type. RPQ
interval total scores had strong concurrent validity
with quality-of-life outcomes and were correlated with
post-injury neurological and psychological comorbid
illness.
Utilizing the super-item approach and thereby atten-
uating the presence of method effects, we presented
clear evidence on the structural validity of the RPQ,
as representing a unidimensional construct of PCS
symptoms for both TBI and orthopedic patients.
Multi-dimensionality as reported previously may
not be due to local trait dependency, but instead to
responses across items influencing each other (local
response dependency), or method effects, as shown by
our study.
Our results are in contrast with other studies using
both Rasch and factor analysis that have so far lent
support to multi-dimensionality, comprising various
factor solutions.11,12,29–31 A previous Rasch study
by Eyres and colleagues11 found evidence of a two-
dimensional model consisting of a mixture of somatic
and psychosomatic symptoms for patients with TBI
assessed between 3 and 6 months post-injury. Lannsjö
and colleagues12 in their Rasch analysis employed a
combination of item rescoring and the super-item ap-
proach, but were not able to resolve underlying issues
around significant item-trait interaction noted in the
scale. They concluded the possibility of three or more
dimensions underpinning PCS symptoms for patients
at 3 months post-TBI. Inconsistent results and persis-
tent ambiguity around factor structure of the RPQ
has to date led to challenges in the calculation and in-
terpretability of summary scores.14 The evidence pre-
sented in this study therefore alleviates some of this
uncertainty about factor structure of PCS symptoms.
It is worth noting that in the two Rasch studies pre-
viously conducted on the RPQ, and other investiga-
tions using factor analysis, symptoms were usually
assessed in the acute symptom stage, typically within
the first 3 to 6 months after TBI. These studies are
marked by fluctuating symptom presentation in pa-
tients, which may be reflected in some of the collective
evidence for a multi-dimensional structure of symp-
toms appearing in the first year after TBI. In contrast,
in our study symptoms were assessed within a mid-
late recovery period, at approximately mean 2.5 years
after injuries, which may partly explain our findings
for a unidimensional construct of PCS symptoms in
both groups. One may postulate whether this finding
of unidimensionality may be attributed to the existence
of long-term stable symptoms that occur after the
experience of an injury. Evidence from a study by
Barker-Collo and colleagues31 seem to support the
notion that temporal changes occur within the factor
structure for the TBI population, in which symptom
structure is best defined by three factors in the first
month, whereas two factors appear to describe the
data better at 6 and 12 months. The authors thus con-
cluded that there appears to be a relative stability in fac-
tor structure after 6 months, distinguishing between
dynamic or early symptoms that are present in the
first 3 months, and the persistence of more stable
symptoms thereafter.
A later investigation by Barker-Collo and col-
leagues13 revealed evidence for a one-factor structure
of PCS symptoms appearing among patients with
TBI at 4 years post-injury. This concept of transient
versus stable dimensions of PCS symptoms was further
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explored statistically by Medvedev et al.32 using Gener-
alizability Theory. It was concluded from their analysis
that although the RPQ is a reliable measure in assessing
enduring symptoms at 6–12 months, it is however lim-
ited in its ability to assess dynamic symptoms that fluc-
tuate across the initial days and weeks following TBI.
Few studies exist on the temporality of PCS symptoms;
however, the available evidence does collectively seem
to suggest that symptom dimensions are likely to amal-
gamate as the time elapsed since injury increases.
Detailed examination of the individual items in our
analysis confirmed previous Rasch work that items
function invariantly by age and sex.11,12 Another
strength of our study is that we were able to assess
DIF by injury group and showed that RPQ items func-
tion effectively among those with TBI and orthopedic
injuries, for ethnicity, and for symptoms in the early
to mid-recovery and mid to late-recovery periods.
These findings indicate that the unitary construct of
the RPQ is similar for both TBI and orthopedic popu-
lations, and that the RPQ can be reliably administered
to both populations as a measure of long-term symp-
toms. It remains to be seen whether the structure of
symptoms among orthopedic patients will follow a
trajectory similar to that in patients with TBI—from
symptoms appearing multi-dimensional in the first
few months after injury, to a more unidimensional
structure with increased time.
In the extant literature, the evidence gathered so far
on PCS symptoms appears to fuel the long-standing
debate as to whether the appearance of this constella-
tion of symptoms is unique to individuals with TBI.
The lack of specificity of the RPQ is further empirically
supported by evidence from studies on the existence of
PCS-like symptoms in various groups such as among
patients with chronic pain,15 depression,33 orthopedic
injuries,17 and even in healthy samples.8,34 As early as
the 1980s, several researchers had already begun to
question the specificity of this phenomenon.35–37 In
fact, Lishman35 argued that there is no apparent de-
marcation between symptoms that are solely attrib-
utable to neurobiological mechanisms of a cerebral
injury, known as physiogenic factors, and symptoms
that occur circumstantially to the experience of an in-
jury, traumatic experience, or those masked as daily
stressors. The latter have been collectively termed psy-
chogenic factors. It is also important to note that these
factors do not need to occur in a mutually exclusive
manner, but can arise in combination.38 Aside from
these theoretical debates on the misclassification of
PCS, the evidence nevertheless points to the com-
monality in symptoms with non-TBI individuals.
This evidence needs to be explored further by methods
such as network analysis,39 and should include further
validation of PCS symptom scales for their potential
use in other populations, which is currently lacking.
The achievement of a unidimensional fit of the RPQ
discussed earlier has several implications, the first being
that it is a prerequisite for the calculation of a single
total score.40 The conversion to an interval measure-
ment provided herein allows the summation of item
scores, which can facilitate clinicians’ assessment of
change scores at various stages of a patient’s recovery.
From a statistical perspective, these conversions from
ordinal to interval level also strengthen the precision
of the scale by permitting the use of parametric test-
ing methods that would otherwise violate the required
assumptions. Our comparisons between the ordinal
scores and interval scores showed a considerable differ-
ence, where corresponding mean interval scores on
the RPQ would result in an increase by a mean of 10
points. The conversion table shows that the magnitude
of score differences is mostly concentrated in the
lower-most end of the spectrum, among individuals
who are seemingly asymptomatic but who may actually
be experiencing at least some symptoms of PCS. Last,
having demonstrated unidimensionality and conver-
sion to interval total scores, this study may serve as a
starting point for researchers to develop thresholds
for the RPQ to be used as a diagnostic instrument.
This may help to determine to what degree collective
symptoms indicate the severity of PCS in an individual,
and at what cutoff score clinical intervention may be
deemed necessary.
Limitations
Some study limitations need to be considered. First,
this study represents a cross-sectional snapshot of
symptoms reported at different time intervals, with a
mean time centering around 2.5 years post-injury.
Therefore, for some participants, especially those in
the later stages of recovery, their experience of symp-
toms may not necessarily indicate late sequelae of
injuries, but rather environmental stressors, for exam-
ple, life events or stress-coping mechanisms.41 Also, in
our study we found that the coverage was poor for the
orthopedic sample, with only 65% coverage by items.
Although this may not be seen as an outright limita-
tion, it suggests that the informational value provided
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by the RPQ for the orthopedic sample is limited, espe-
cially for those presenting with no to very minor symp-
toms. As ours is the only study to have attempted
validation of a PCS measure in this population, further
research in this population is needed to substantiate
these findings.
Another limitation is that the assumption that most
of the TBI cases were mild was based on GCS scores,
which were only available for two-thirds of the sample.
Lack of complete data or inconsistent recording of GCS
scores are not unique to our study; they are common
occurrences in hospital registries.42 In addition, as
case patients were recruited from hospitalizations, it
may be that our sample represents patients with more
‘‘complicated’’ injuries within the spectrum, who may
differ in symptom presentation compared with those
with ‘‘uncomplicated’’ mild cases who do not present
to the hospital.43 It is also likely that some individuals
with orthopedic injuries may not have been assessed
for the possibility of a TBI, thereby undercounting
the true extent of individuals with TBI in our sample.
In our study, isolated TBI cases were combined with
multiply injured TBI cases (i.e., TBI with extracranial
injuries) to improve statistical power for analysis,
which may have inadvertently introduced some degree
of confounding.
Last, we acknowledge that different approaches are
undertaken to derive total scores, with King and col-
leagues9 excluding all responses of 1, ‘‘no more of a
problem,’’ to detect change in symptoms since injury.
Other studies including for Rasch analysis have either
combined response categories 0, and 1,11 or included
all response categories in the total score.3,12 Our analy-
sis followed the convention used by Lannsjö and asso-
ciates12 to include all scores in the calculation of the
total score, given that the assumption of unidimension-
ality has been met. In the extant literature there exists
no gold standard on how the RPQ should be scored,
and therefore care needs to be taken during interpre-
tation of total scores, particularly when comparing
between individuals.
Conclusion
Our findings through Rasch analysis confirm that the
RPQ remains a reliable measure that can be used as a
tool for individual assessment of long-term PCS symp-
toms in both TBI and orthopedic populations. Utilizing
a subtest approach to correct for the presence of
method effects in items, our results produced evidence
of a unidimensional construct of symptoms, which
helps elucidate previous inconsistent findings on its
structural validity. The conversion of scores provided
allow for the calculation of summary scores and is a
useful starting point for comparing between individu-
als for clinical and research purposes, and possibly
for the future development of cutoff total scores to
establish clinical thresholds. Further research is needed
to ascertain whether the RPQ can be used as a reliable
measure in other populations that have been found to
experience PCS-like symptoms.
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